Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2005
08/18/2005WO2005075453A1 Linker compound, ligand complex and process for producing them
08/18/2005WO2005075448A2 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained
08/18/2005WO2005075022A2 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment
08/18/2005WO2005075004A1 Method and apparatus for organ regeneration and method of screening drug promoting organ regeneration
08/18/2005WO2005074996A2 Lat1 transporter expressed in blood brain barrier cells
08/18/2005WO2005074994A1 Oat3 transporter expressed in blood brain barrier cells
08/18/2005WO2005074980A1 Treatment of neurodegenerative diseases by the use of gpr49
08/18/2005WO2005074971A1 Treatment of neurodegenerative diseases by the use of cgi-13 interacting molecules
08/18/2005WO2005074969A2 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a1 (nr4a1)
08/18/2005WO2005074941A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
08/18/2005WO2005074923A1 Methods and compositions
08/18/2005WO2005074921A1 Treatment of atherosclerosis
08/18/2005WO2005074811A1 Method for detecting artifacts in data
08/18/2005WO2005074692A1 Table of botanical ingredients and method of preparing a table useful for blending combinations thereof
08/18/2005WO2005074681A2 Apparatus and method for determining effects of a substance on an organ
08/18/2005WO2005074650A2 Modified human four helical bundle polypeptides and their uses
08/18/2005WO2005074646A2 Methods and systems for joint analysis or array cgh data and gene expression data
08/18/2005WO2005074641A2 Variant neuronal nicotinic alpha-7 receptor and methods of use
08/18/2005WO2005074633A2 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
08/18/2005WO2005074609A2 Test strip composition and method to measure cholesterol from low density lipoproteins
08/18/2005WO2005074604A2 METHODS OF DETECTING Lp-PLA2 ACTIVITY
08/18/2005WO2005074572A2 Methods and compositions for detecting of equine tapeworm infections
08/18/2005WO2005074553A2 Tablet holder device and methods for immersion testing
08/18/2005WO2005074546A2 Modified human growth hormone polypeptides and their uses
08/18/2005WO2005074541A2 Detection of biological and chemical agents
08/18/2005WO2005074524A2 Modified human interferon polypeptides and their uses
08/18/2005WO2005074467A2 Matrix array nanobiosensor
08/18/2005WO2005074461A2 Kits and methods for autoantibody detection
08/18/2005WO2005074460A2 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
08/18/2005WO2005074436A2 Self-assembling split-fluorescent protein systems
08/18/2005WO2005074381A2 Induction of apoptosis via arts-iap complexes
08/18/2005WO2005066639A3 Affinity displacement avidity effect protein resolution methods
08/18/2005WO2005062405A3 Electrode for use in electrochemical sensor
08/18/2005WO2005056146A3 Method of detection, separation and identification for expressed trace protein/peptide
08/18/2005WO2005056145A3 Biological chip and use thereof
08/18/2005WO2005054810A3 Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression
08/18/2005WO2005050200A9 Screening assays and methods of tumor treatment
08/18/2005WO2005048834A8 Long term analyte sensor array
08/18/2005WO2005047242A3 Compounds containing thiosulfate moieties
08/18/2005WO2005045056A3 Radioactive multiplexing analytical methods
08/18/2005WO2005043162A3 Method for distinguishing mll-ptd-positive aml from other aml subtypes
08/18/2005WO2005042559A9 Capture and release based isotope tagged peptides and methods for using the same
08/18/2005WO2005037323A3 Use of gro to treat or prevent inflammation
08/18/2005WO2005029067A3 Method of diagnosing breast cancer
08/18/2005WO2005026741A3 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
08/18/2005WO2005024383A9 Methods employing combinatorial artificial receptors
08/18/2005WO2005024065A3 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same
08/18/2005WO2005021799A3 Materials and methods for capture of pathogens and removal of aurintricarboxylic acid from a sample
08/18/2005WO2005020924A3 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
08/18/2005WO2005020794A8 Taxane chemosensitivity prediction test
08/18/2005WO2005019419B1 Co-detection of single polypeptide and polynucleotide molecules
08/18/2005WO2005018436A3 Methods for the diagnosis, prognosis and treatment of metabolic syndrome
08/18/2005WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus
08/18/2005WO2005015207A3 Method and diagnostic tests based on flow cytometric analysis of antigen-specific t lymphocytes
08/18/2005WO2005014857A3 Nucleic acid arrays for detecting multiple strains of a non-viral species
08/18/2005WO2005013899A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/18/2005WO2005010044A3 Il-17 a/f heterologous polypeptides and therapeutic uses thereof
08/18/2005WO2005007868A3 Controlled platelet activation to monitor therapy of adp antagonists
08/18/2005WO2005007691A3 East coast fever vaccine based on ctl-specific schizont antigens
08/18/2005WO2005006959A3 Compact analyte testing cassette with true positive and negative analyte controls
08/18/2005WO2005003376A3 Anthrax antigen vaccine cultures by fluorescence polarization
08/18/2005WO2005003291A3 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
08/18/2005WO2004113919A3 Nano and micro-technology virus detection method and device
08/18/2005WO2004088272A3 Methods to identify biologically active agents and synergistic combinations
08/18/2005WO2004072608A3 Biosensor and use thereof to identify therapeutic drug molecules and molecules binding orphan receptors
08/18/2005WO2004066946A3 Method for evaluating the efficacy of certain cancer treatments
08/18/2005WO2004048541A3 Cct6s as modifiers of the rb pathway and methods of use
08/18/2005WO2004045519A3 Induction of apoptosis by hiv-1 infected monocytic cells
08/18/2005WO2004031809A8 Optical tomography of small moving objects using time delay and integration imaging
08/18/2005WO2003089895A3 Methods for the electrochemical detection of multiple target compounds
08/18/2005WO2003063690A3 Secreted caveolin as a marker for prostate cancer
08/18/2005WO2003004608A3 Drug metabolizing enzymes
08/18/2005WO2002099049A3 Tbc1d1s as modifiers of the p53 pathway and methods of use
08/18/2005WO2001058923A9 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
08/18/2005US20050183165 Grapevine leafroll virus (type 2) proteins and their uses
08/18/2005US20050183148 Lymphocyte surface receptor that binds caml and methods of use thereof
08/18/2005US20050183146 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
08/18/2005US20050183144 Gab1 involvement in glucose homeostasis regulation by hepatocytes
08/18/2005US20050182574 Device for detecting hydrogen concentration and method of detecting hydrogen concentration
08/18/2005US20050182572 heating an aluminum substrate to a predetermined temperature, then contacting with the a sample including fuel additives and determining the amount of deposits formed on the substrate after a predetermined period of time; transferring the deposit formation data to computer controllers
08/18/2005US20050182570 Process for identifying similar 3D substructures onto 3D atomic structures and its applications
08/18/2005US20050182569 Method for testing for bioaccumulation
08/18/2005US20050182568 Method for evaluating a patients biological condition
08/18/2005US20050182566 Method and apparatus for determining filtrate contamination from density measurements
08/18/2005US20050182311 Blood sugar level measuring apparatus
08/18/2005US20050182310 Blood sugar level measuring apparatus
08/18/2005US20050182307 Systems and methods for monitoring health and delivering drugs transdermally
08/18/2005US20050182303 System for improving antibiotic use in acute care hospitals
08/18/2005US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis
08/18/2005US20050182249 Nucleotide sequences coding tumor suppressor protein for use in diagnosis, prevention and treatment of cancer; antitumor agents
08/18/2005US20050182246 An active site containing a hydrophobic surface of a binding pocket of amino acid residues Tyr-161, Phe-157, Arg-186, Leu-182, Arg-117, Phe-134, Leu-135, Leu-154, Phe-149, Ile-142, His-146, Arg-114, Lys-190, Ser-193, Ala-158, Tyr-138, Leu-115, Met-123, Phe-165, and Pro-118; improved gas binding property
08/18/2005US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/18/2005US20050182242 Microarray comprising double tagged fusion protein for monitoring and classification of polypeptide interactions in preferential species; high-throughput assay
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182011 Use inhibitors of Transient Receptor Potential (TRP) channels to block non-voltage gated calcium flux into cells
08/18/2005US20050181982 Crystal structures of anti-factor IX Fab fragments and methods of use for peptidomimetic design
08/18/2005US20050181980 Administering a formulation comprising an effective amount of:a sulfonylurea receptor 1 (SUR1) antagonist that reduces the activity of a NCCa-ATP channel; a pharmaceutically acceptable carrier
08/18/2005US20050181975 Crystal structure of FMS-like tyrosine kinase
08/18/2005US20050181974 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
08/18/2005US20050181521 Sampling and assay device together with methods for use thereof
1 ... 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 ... 3937